The most consistently reported difference is in the distribution of tumor histologies; BRCA1 mutation carriers tend almost exclusively to develop serous ovarian cancer, whereas a considerable fraction of sporadic ovarian cancers are of endometrioid, mucinous, or clear-cell histology [38],[39],[51],[52]. Here, BRCA1 is linked to ovarian serous adenocarcinoma.